Clinical Trial of GAIA-102 for Advanced and Relapse NSCLC

Clinical trial NCT05207371 · UNKNOWN

Trial details

NCT number: NCT05207371
Sponsor: GAIA BioMedicine Inc.
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cell Therapy NSCLC

Start date: 2021-12-01
Primary completion: 2022-10-01
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.